AbstractHIVINTEREST 2020Targeted CQI improves Early Retention of HIV+ Clients Newly Initiated on Anti-retro-viral Therapy; Lessons from the Pediatric Infectious Diseases Clinic-Mulago, Uganda.View Abstract
AbstractHIVINTEREST 2020“One size does not fit all” – views by stakeholders, men on ART and men in communities on improving men’s access to and continued engagement in ART in MalawiView Abstract
AbstractHIVINTEREST 2020Improving viral load suppression rates among HIV positive children on ART in a large volume HIV clinic in Western Uganda.View Abstract
AbstractHIVINTEREST 2020Prevalence and factors associated with delayed antiretroviral therapy switching at rural public health facilities in Kiboga district, Uganda.View Abstract
AbstractHIVINTEREST 2020Using analysis of Viral Load Result for Targeted Index Testing (using 3rd 90 to achieve 1st 90)View Abstract
AbstractHIVINTEREST 2020Acquired drug resistance patterns and implications of use of tenofovir-lamivudine-dolutegravir (TLD) as second- or third-line regimens: evidence from real life experience in CameroonView Abstract
AbstractHIVINTEREST 2020Burnett Plasma Separation device as alternative for HIV Viral Load DeterminationView Abstract
AbstractHIVINTEREST 2020Accurate HIV Viral Load in Primary Healthcare Centers using Plasma Separation CardsView Abstract
AbstractHIVINTEREST 2020Where are the men in Gaza? A cross-sectional study to understand the residency patterns of male partners of women accessing HIV services in Gaza, MozambiqueView Abstract
AbstractHIVINTEREST 2020In Urban settings, Vertically-Infected Adolescents Experience Treatment Failure driven by HIV Drug Resistance Emergence: Results from a Follow-up Analysis in CameroonView Abstract
AbstractHIVINTEREST 2020Low Baseline-Resistance to Integrase Inhibitors in Cameroon: Implications in the Era of Dolutegravir-based Regimens in Sub-Saharan AfricaView Abstract
AbstractHIVINTEREST 2020Zimbabwe’s National Third-Line Antiretroviral Therapy Program: Cohort Description and Treatment OutcomesView Abstract
